<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:aavptbiennial-ojs-tamu.tdl.org:article/131</identifier>
				<datestamp>2024-10-30T18:54:07Z</datestamp>
				<setSpec>aavptbiennial:SII</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Recent Advances in Autonomic Pharmacology: Adrenoceptor-Selective Agonists and Antagonists</dc:title>
	<dc:creator xml:lang="en">Adams, H. Richard</dc:creator>
	<dc:subject xml:lang="en">autonomic nervous system</dc:subject>
	<dc:subject xml:lang="en">pharmacologic responsiveness</dc:subject>
	<dc:subject xml:lang="en">autonomic drugs</dc:subject>
	<dc:subject xml:lang="en">cellular function</dc:subject>
	<dc:description xml:lang="en">An important characteristic of the autonomic nervous system is its susceptibility to pharmacologic and toxicologic actions of a rather broad and diversified group of drugs, endogenous agents, and environmental chemicals. This susceptibility is prevalent in both sympathetic and parasympathetic efferent (motor) nerve tracts, the two principal divisions of the autonomic system, and it is manifested at virtually all nerve-nerve and nerve-effector cell junctions which comprise cell to cell communication points along the autonomic outflow paths.
Pharmacologic responsiveness of autonomically innervated cells is good in one respect because drugs that mimic autonomic activity can be used to improve, assist, or otherwise affect dysfunctional tissue. Historically, however, clinicians have encountered difficulty in achieving selective autonomic drug actions only on pathophysiologic defects in one tissue type without also affecting normal cellular functions in other organs. This is true, no doubt, because of many intertissue similarities in basic physiologic processes responsible for communication of impulse messages across the various autonomic neuroeffector junctions. Autonomic reflex mechanisms have further complicated attempts to develop selective drugs without significant direct, or indirect (reflex) side effects on nontarget cells.</dc:description>
	<dc:publisher xml:lang="en">AAVPT Biennial Symposia</dc:publisher>
	<dc:date>1982-04-13</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/131</dc:identifier>
	<dc:source xml:lang="en">AAVPT Biennial Symposia; Third Symposium; 145-152</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://aavptbiennial-ojs-tamu.tdl.org/aavptbiennial/article/view/131/125</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 1982 American Academy of Veterinary Pharmacology and Therapeutics</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
